Surfactant Free Delivery of Docetaxel by Poly[(R)‐3‐hydroxybutyrate‐(R)‐3‐hydroxyhexanoate]‐Based Polymeric Micelles for Effective Melanoma Treatments

Poly(PHBHx/PEG/PPG polyurethane) containing flexible and biodegradable PHBHx segments are designed to encapsulate docetaxel (DTX) in a nanosized micelle formulation, instead of with surfactants with undesired hemolysis or hypersensitivity effects. This drug‐loaded polymeric micelle formulation exhibits high drug‐loading efficiency, significantly reduced hemolysis, and effective drug intake in solid tumors, indicating the possibility of chemotherapeutic systematic delivery for better patient compliance.

Abstract

Docetaxel (DTX) is a new semisynthetic chemical in the taxoid family and serves a wide spectrum of chemotherapeutics. Current commercial formulation of DTX is based on the addition of the nonionic surfactants (i.e., ethanol and Tween 80), which are reported to cause severe hemolysis, hypersensitivity reactions, or neurotoxic toxicity and greatly hinders patient tolerance or compliance. In this report, a novel low‐toxic, biodegradable, and amphiphilic poly[(R)‐3‐hydroxybutyrate‐(R)‐3‐hydroxyhexanoate] (PHBHx)‐based polyurethane (a copolymer made of hydrophobic PHBHx with biocompatible D‐3‐hydroxybutyric acid as degradation product, thermosensitive polypropylene glycol (PPG), and hydrophilic polyethylene glycol (PEG) segments) with nanosized micelle formation ability to encapsulate DTX, as a surfactant free formulation, is reported. Interestingly, this DTX‐loaded poly(PHBHx/PEG/PPG urethane) micelle formulation with >90% drug loading efficiency shows significantly improved DTX solubility in aqueous medium, reduced hemolysis for better blood compatibility, and increased drug uptake in A375 melanoma cells, which provides the possibility of systematic delivery of DTX. As a proof‐of‐concept, an A375 melanoma xenograft mouse model is established to verify the therapeutic effect of this DTX‐loaded poly(PHBHx/PEG/PPG urethane) micelle formulation, indicating the promising application of PHBHx‐based polymeric nanosized micelle as a surfactant free formulation of chemotherapeutics which might greatly be beneficial for controllable delivery of pharmaceutics and cancer therapy.

https://ift.tt/2qvwBkU